link to webcast
Category: Webcast
2023 Half-year results and business update
link to webcast
New Leadership Structure to Accelerate the Development of its Innovative Immunotherapy Portfolio
link to webcast
2022 Full-year results and business update
Link to webcast
Transgene R&D Day (Paris, France)
Lien
TG4050, First positive clinical data from Phase I clinical trials
link to webcast
Detailed results of the Phase 1b/2 trial of TG4001 and avelumab in advanced HPV-positive cancers presented at SITC 2020
Link to webcast